Dianthus Therapeutics (DNTH) Assets Growth (1y) (2018 - 2025)
Powered by 
Analysis
Dianthus Therapeutics (DNTH) Assets Growth (1y) (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Dianthus Therapeutics | 4.09 Bn | 3.69 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 41.95% |
| Sep 30, 2025 | 63.01% |
| Jun 30, 2025 | -11.62% |
| Mar 31, 2025 | -8.86% |
| Dec 31, 2024 | 108.47% |
| Sep 30, 2024 | 84.06% |
| Jun 30, 2024 | 369.19% |
| Mar 31, 2024 | 358.36% |
| Dec 31, 2023 | 115.86% |
| Sep 30, 2023 | 17.27% |
| Jun 30, 2023 | -55.10% |
| Mar 31, 2023 | -57.07% |
| Dec 31, 2022 | -56.24% |
| Sep 30, 2022 | -20.42% |
| Jun 30, 2022 | -20.54% |
| Mar 31, 2022 | 34.41% |
| Dec 31, 2021 | 17.52% |
| Sep 30, 2021 | 18.09% |
| Jun 30, 2021 | 15.55% |
| Mar 31, 2021 | 0.12% |